130596-62-2

Basic information

• Product Name: 4,4-dimethyl-1,4-azasilinane hydrochloride
• Synonyms: 4,4-dimethyl-1,4-azasilinane hydrochloride;4,4-DIMETHYL-1,4-AZASILINANE HCL
• CAS NO: 130596-62-2
• Molecular Formula: C₆H₁₅NSi*ClH
• Molecular Weight: 165.73644
• Mol File: 130596-62-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4,4-dimethyl-1,4-azasilinane hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4,4-dimethyl-1,4-azasilinane hydrochloride(130596-62-2)
• EPA Substance Registry System: 4,4-dimethyl-1,4-azasilinane hydrochloride(130596-62-2)

Safety Data

• Hazardous Substances Data: 130596-62-2(Hazardous Substances Data)

Usage

General Description

4,4-dimethyl-1,4-azasilinane hydrochloride, also known as DM-1, is a chemical compound that belongs to the class of azasilinane derivatives. It is commonly used in the pharmaceutical industry as a reagent for the synthesis of various organic compounds and pharmaceutical drugs. DM-1 is a water-soluble and stable compound that is used as a building block in the development of new drug molecules. It has potential therapeutic applications in the treatment of various medical conditions, including cancer and neurological disorders. Additionally, DM-1 has been studied for its potential antimicrobial properties, making it a valuable compound for the development of new antimicrobial agents. Overall, 4,4-dimethyl-1,4-azasilinane hydrochloride is a versatile and important chemical compound with promising applications in the pharmaceutical and medical fields.

Upstream product

• 51664-50-7 dimethylbis(2-bromoethyl)silane 
• 10519-87-6 divinyldimethylsilane 
• 130596-60-0 1-benzyl-4,4-dimethyl-1,4-azasilinane 
• 130596-61-1 1-benzyl-4,4-dimethyl-[1,4]azasilinane hydrochloride 

Downstream Products

• 1430321-42-8 1-(2-fluoro-4-nitrophenyl)-4,4-dimethyl-1,4-azasilinane 
• 1430321-66-6 1-(2,6-difluoro-4-nitrophenyl)-4,4-dimethyl-1,4-azasilinane 
• 1430321-69-9 (R)-5-(azidomethyl)-3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)oxazolidin-2-one 
• 1430321-51-9 (R)-5-(azidomethyl)-3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3-fluorophenyl)oxazolidin-2-one 
• 1430321-68-8 (R)-(3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate 
• 1430321-64-4 (S)-tert-butyl ((3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)-2-oxooxazolidin-5-yl)methyl)carbamate 
• 1430321-59-7 (R)-5-((1H-l,2,3-triazol-1-yl)methyl)-3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)oxazolidin-2-one 
• 1430321-52-0 (R)-5-((1H-1,2,3-triazol-1-yl)methyl)-3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3-fluorophenyl)oxazolidin-2-one 
• 1430321-58-6 (R)-3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one 
• 1430321-49-5 (R)-3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one 
• 1430321-57-5 (S)-O-methyl (3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)-2-oxooxazolidin-5-yl)methylcarbamothioate 
• 1430321-48-4 (S)-O-methyl ((3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3-fluorophenyl)-2-oxooxazolidin-5-yl)methyl)carbamothioate 
• 1430321-56-4 (S)-methyl (3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3,5-difluorophenyl)-2-oxooxazolidin-5-yl)methylcarbamate 
• 1430321-47-3 (S)-methyl ((3-(4-(4,4-dimethyl-1,4-azasilinan-1-yl)-3-fluorophenyl)-2-oxooxazolidin-5-yl) methyl)carbamate 

Relevant articles and documents

Substituted benzimidazole derivatives

The invention belongs to the field of pharmaceutical chemistry, particularly relates to substituted benzimidazole derivatives as well as a preparation method and pharmaceutical composition thereof and further relates to an application of the substituted b

SILA ANALOGS OF OXAZOLIDINONE DERIVATIVES AND SYNTHESIS THEREOF

The invention discloses silaanalogs of oxazolidinone compounds, to pharmaceutical compositions and to the synthesis of the oxazolidinone derivatives of formula I. The invention further relates to methods of treating a subject suffering with gram positive pathogens including those resistant to methicillin and vancomycin using the compound(s) or modulation of coagulation properties of blood-clotting cascade or compositions of the oxazolidinone derivatives of the invention.

NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES

The present invention relates to novel triazolopyrimidine derivatives of formula (I) as active ingredients which have microbiocidal activity, in particular fungicidal activity: wherein the substituents are as defined in claim 1.